Filing Details

Accession Number:
0001104659-19-056270
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-10-25 06:21:09
Reporting Period:
2019-10-07
Accepted Time:
2019-10-25 06:21:09
Original Submission Date:
2019-10-09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1734517 Viela Bio Inc. VIE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789666 Xiaomeng Tong C/O Boyu Capital Advisory Co. Limited
Suite 1518, Two Pacific Pl, 88 Queensway
Hong Kong
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-07 6,800,000 $0.00 6,800,000 No 4 C Indirect Held by Boundless Meadow Limited
Common Stock Acquisiton 2019-10-07 1,882,353 $0.00 8,682,353 No 4 C Indirect Held by Boundless Meadow Limited
Common Stock Acquisiton 2019-10-07 300,000 $19.00 300,000 No 4 P Indirect Held by Boyu Capital Opportunities Master Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Held by Boundless Meadow Limited
No 4 C Indirect Held by Boundless Meadow Limited
No 4 P Indirect Held by Boyu Capital Opportunities Master Fund
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-2 Preferred Stock Disposition 2019-10-07 6,800,000 $0.00 6,800,000 $0.00
Common Stock Series A-3 Preferred Stock Disposition 2019-10-07 1,882,353 $0.00 1,882,353 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis.
  2. The shares are directly held by Boundless Meadow Limited. Boundless Meadow Limited is wholly owned by Boyu Capital Fund III, L.P. Boyu Capital General Partner III, L.P. is the general partner of Boyu Capital Fund III, L.P. Boyu Capital General Partner III, Ltd. is the general partner of Boyu Capital General Partner III, L.P. Boyu Capital Group Holdings Ltd. holds 100% of the outstanding shares of Boyu Capital General Partner III, Ltd. XYXY Holdings Ltd. is the controlling shareholder of Boyu Capital Group Holdings Ltd. Mr. Tong holds 100% of the outstanding shares of XYXY Holdings Ltd. Mr. Tong indirectly controls Boundless Meadow Limited and may be deemed to beneficially own the shares held by Boundless Meadow Limited. Mr. Tong disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any.
  3. The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering
  4. Not applicable.
  5. Reflects shares purchased in the Issuer's initial public offering.
  6. The shares are directly held by Boyu Capital Opportunities Master Fund. Boyu Capital Investment Management Limited holds 100% of management shares of Boyu Capital Opportunities Master Fund. Boyu Capital Group Holdings Ltd. holds 100% of the voting shares of Boyu Capital Investment Management Limited. XYXY Holdings Ltd. is the controlling shareholder of Boyu Capital Group Holdings Ltd. Mr. Tong holds 100% of the outstanding shares of XYXY Holdings Ltd. Mr. Tong indirectly controls Boyu Capital Opportunities Master Fund and may be deemed to beneficially own the shares held by Boyu Capital Opportunities Master Fund. Mr. Tong disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any.
  7. This amendment is being filed solely to correct a mathematical error in the amount of shares beneficially owned following the reported transactions as reflected in the Form 4 filed on October 9, 2019.